InsiderClue
Insiders · Profile

Topper James N

Director at NewAmsterdam Pharma Co N.V · Director at Phathom Pharmaceuticals · Director at ANAPTYSBIO. Filing since 31 Jan 2017. CIK 0001341382

NAMS NewAmsterdam Pharma Co N.V. Director · 9 trades PHAT Phathom Pharmaceuticals, Inc. Director · 5 trades ANAB ANAPTYSBIO, INC Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
NAMS NewAmsterdam Pharma Co N.V.
15 Sep 2025
Director
Bought
660
$15.64K
0.0%
NAMS NewAmsterdam Pharma Co N.V.
8 Sep 2025
Director
Bought
1,260
$31.49K
0.0%
NAMS NewAmsterdam Pharma Co N.V.
11 Aug 2025
Director
Bought
471
$11.29K
0.0%
NAMS NewAmsterdam Pharma Co N.V.
25 Jun 2025
Director
Bought
1,260
$23.01K
0.0%
NAMS NewAmsterdam Pharma Co N.V.
24 Jun 2025
Director
Bought
2,520
$46.45K
0.1%
NAMS NewAmsterdam Pharma Co N.V.
16 Jun 2025
Director
Bought
8,584
$167.38K
0.3%
PHAT Phathom Pharmaceuticals, Inc.
21 May 2025
Director
Bought
3,780
$14.61K
6.8%
PHAT Phathom Pharmaceuticals, Inc.
14 May 2025
Director
Bought
6,300
$20.92K
12.8%
PHAT Phathom Pharmaceuticals, Inc.
13 May 2025
Director
Bought
1,120
$3.54K
2.3%
PHAT Phathom Pharmaceuticals, Inc.
12 May 2025
Director
Bought
12,601
$38.30K
35.4%
PHAT Phathom Pharmaceuticals, Inc.
9 May 2025
Director
Bought
35,602
$114.62K
opened
NAMS NewAmsterdam Pharma Co N.V.
26 Mar 2025
Director
Bought
1,135
$25.52K
0.0%
NAMS NewAmsterdam Pharma Co N.V.
4 Mar 2025
Director
Bought
4,005
$84.20K
0.1%
NAMS NewAmsterdam Pharma Co N.V.
26 Mar 2024
Director
Bought
8,429
$181.22K
0.3%
ANAB ANAPTYSBIO, INC
31 Jan 2017
Director
Bought
400,000
$6.00M
62.0%
15 decisions on file.